LMR Partners’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,000
| Closed | -$218K | – | 996 |
|
|
2023
Q4 | $218K | Hold |
10,000
| – | – | ﹤0.01% | 415 |
|
|
2023
Q3 | $153K | Hold |
10,000
| – | – | ﹤0.01% | 454 |
|
|
2023
Q2 | $238K | Sell |
10,000
-10,000
| -50% | -$238K | ﹤0.01% | 456 |
|
|
2023
Q1 | $509K | Sell |
20,000
-30,000
| -60% | -$763K | 0.01% | 713 |
|
|
2022
Q4 | $1.46M | Buy |
50,000
+9,213
| +23% | +$269K | 0.03% | 607 |
|
|
2022
Q3 | $837K | Sell |
40,787
-39,610
| -49% | -$813K | 0.02% | 766 |
|
|
2022
Q2 | $930K | Buy |
80,397
+27,623
| +52% | +$320K | 0.02% | 783 |
|
|
2022
Q1 | $976K | Buy |
52,774
+11,374
| +27% | +$210K | 0.01% | 832 |
|
|
2021
Q4 | $818K | Buy |
41,400
+7,892
| +24% | +$156K | 0.01% | 779 |
|
|
2021
Q3 | $551K | Buy |
+33,508
| New | +$551K | 0.01% | 758 |
|
|
2019
Q4 | – | Sell |
-989
| Closed | -$11K | – | 560 |
|
|
2019
Q3 | $11K | Hold |
989
| – | – | ﹤0.01% | 411 |
|
|
2019
Q2 | $30K | Buy |
+989
| New | +$30K | ﹤0.01% | 390 |
|